It's interesting that the insiders are buying. They seem to think anything below RM7 is a buy.

Nobody is expecting glove sales to go back to pre-covid levels.

The average analyst prediction for revenue in FY22 is roughly RM15bn.

Throw in the predicted RM10bn profits for FY21 and you have a bargain stock.

Sales will decline in FY23 but will still be way higher than FY19.

https://www.theedgemarkets.com/article/bull...21-falling-fy22

Yeah, that's not what the analysts are predicting though.

Face masks are being bought by individuals but gloves aren't. Gloves are bought by hospitals and medical facilities mostly. Hospitals in Europe and the US are running at full capacity, hence the lockdowns. A lot of surgery is being postponed because the hospitals are full of covid patients. When the pandemic ends, those hospitals will return to 90% capacity. Nurses and doctors will still need to wear gloves and dispose of them once used on one patient.

We will see a fall in glove sales but only to 80-90% of pandemic sales.

The analysts are predicting that the demand for gloves will continue to be high through 2023.

https://www.thestar.com.my/business/busines.../strong-rebound